“INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING”. Frontier in Medical and Health Research 4, no. 5 (May 20, 2026): 567–585. Accessed May 21, 2026. https://fmhr.net/index.php/fmhr/article/view/2904.